|
TMEM170A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.18480789015985E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.67009986238054E-10 |
| Normal-vs-Stage2 |
3.27690000001546E-06 |
| Normal-vs-Stage3 |
2.33424390927439E-12 |
| Normal-vs-Stage4 |
8.66849925174051E-11 |
| Stage1-vs-Stage2 |
8.407200E-01 |
| Stage1-vs-Stage3 |
5.223800E-03 |
| Stage1-vs-Stage4 |
2.205600E-02 |
| Stage2-vs-Stage3 |
9.907600E-02 |
| Stage2-vs-Stage4 |
1.002200E-01 |
| Stage3-vs-Stage4 |
9.201000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.31668067746705E-13 |
| Normal-vs-AfricanAmerican |
6.790900E-04 |
| Normal-vs-Asian |
1.47650000004163E-07 |
| Caucasian-vs-AfricanAmerican |
4.132000E-01 |
| Caucasian-vs-Asian |
8.412400E-01 |
| AfricanAmerican-vs-Asian |
5.523400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.60169663590659E-12 |
| Normal-vs-Female |
2.71940248097735E-11 |
| Male-vs-Female |
2.724400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.5735999997778E-08 |
| Normal-vs-Age(41-60Yrs) |
5.41144906662794E-12 |
| Normal-vs-Age(61-80Yrs) |
2.09819939200884E-11 |
| Normal-vs-Age(81-100Yrs) |
5.985900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.758460E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.219500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.887450E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.370200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.074000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.330800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.04990000000072E-05 |
| Classical-VS-Follicular |
9.570200E-01 |
| Classical-VS-Other |
6.757600E-01 |
| Classical-VS-Normal |
8.49470493946569E-11 |
| Tall-VS-Follicular |
4.982300E-04 |
| Tall-VS-Other |
3.067200E-01 |
| Tall-VS-Normal |
4.72510919280467E-13 |
| Follicular-VS-Other |
7.286800E-01 |
| Follicular-VS-Normal |
3.72260000047753E-07 |
| Other-VS-Normal |
8.782800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.39459571563339E-11 |
| Normal-vs-N1 |
7.06890102009083E-11 |
| N0-vs-N1 |
8.776200E-02 |
|
|
